Cresco Labs Inc.
CL
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.02% | -10.15% | -5.73% | -4.53% | -6.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.02% | -10.15% | -5.73% | -4.53% | -6.43% |
| Cost of Revenue | -10.28% | -5.38% | -0.23% | -10.91% | -19.43% |
| Gross Profit | -11.74% | -15.05% | -11.18% | 2.34% | 11.11% |
| SG&A Expenses | -5.58% | 4.28% | 3.45% | -7.35% | -19.06% |
| Depreciation & Amortization | -14.82% | -4.91% | -45.31% | -4.04% | 19.42% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.73% | -1.88% | -1.86% | -9.32% | -18.37% |
| Operating Income | -21.54% | -53.40% | -26.17% | 31.87% | 185.51% |
| Income Before Tax | 106.70% | -105.76% | -76.17% | 109.50% | -38.66% |
| Income Tax Expenses | 62.49% | -20.48% | -67.09% | 430.94% | -26.54% |
| Earnings from Continuing Operations | 72.85% | -641.31% | -90.98% | 93.22% | -17.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.58% | 125.56% | -115.45% | -33.85% | -145.50% |
| Net Income | 69.94% | -177.91% | -265.92% | 90.88% | -48.72% |
| EBIT | -21.54% | -53.40% | -26.17% | 31.87% | 185.51% |
| EBITDA | -20.53% | -40.45% | -28.28% | 17.72% | 86.68% |
| EPS Basic | 70.73% | -171.05% | -261.54% | 91.15% | -35.19% |
| Normalized Basic EPS | 118.76% | -94.95% | -147.86% | 23.08% | -1,566.07% |
| EPS Diluted | 70.73% | -171.05% | -261.54% | 91.15% | -35.19% |
| Normalized Diluted EPS | 118.76% | -94.95% | -147.86% | 23.08% | -1,566.07% |
| Average Basic Shares Outstanding | 2.71% | 2.52% | 2.60% | 2.93% | 9.98% |
| Average Diluted Shares Outstanding | 2.71% | 2.52% | 2.60% | 2.93% | 9.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |